SCHEMBL16623155

SCHEMBL16623155

O=C(CCc1ccc(O)cc1)NCc1cccc(S)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.60
ERCC4 Q92889 1/20 0.60
TRPV1 Q8NER1 4/20 0.58
PTPN1 P18031 1/20 0.50
ALDH1A1 P00352 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GAA P10253 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
SELL P14151 1/20 0.45
SELP P16109 1/20 0.45
SELE P16581 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1894742 0.82 TRPV1 (0.82) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1
SCHEMBL11269450 0.82 TRPV1 (0.82) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1
SCHEMBL6111974 0.81 ERCC1 (0.58) ERCC1ERCC4TRPV1PTPN1ALDH1A1
SCHEMBL24521556 0.80 FFAR1 (0.59) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1
SCHEMBL6111975 0.80 ERCC1 (0.56) ERCC1ERCC4TRPV1PTPN1ALDH1A1
SCHEMBL6111962 0.78 ERCC1 (0.54) ERCC1ERCC4TRPV1PTPN1ALDH1A1
SCHEMBL8377106 0.75 TRPV1 (0.61) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1
SCHEMBL12993898 0.75 TRPV1 (0.61) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1
SCHEMBL26393850 0.74 TRPV1 (1.00) TRPV1ALDH1A1GAAHDAC2HDAC8
SCHEMBL1661081 0.73 TRPV1 (0.76) ERCC1ERCC4TRPV1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212330-B1 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) CHOONGWAE PHARMA CORP (KR) 2015-04-08 EP disclosed